2+ signaling is a major determinant of CD8 + T cell responsiveness, but the mechanisms underlying this regulation of Ca 2+ levels, especially in naïve CD8 + T cells, are not fully defined. Here, we showed that microRNA-150 (miR-150) controls intracellular Ca 2+ levels in naïve CD8 + T cells required for activation by suppressing TMEM20, a negative regulator of Ca 2+ extrusion. miR-150 deficiency increased TMEM20 expression, which resulted in increased intracellular Ca 2+ levels in naïve CD8 + T cells. The subsequent increase in Ca 2+ levels induced expression of anergy-inducing genes, such as Cbl-b, Egr2, and p27, through activation of NFAT1, as well as reduced cell proliferation, cytokine production, and the antitumor activity of CD8 + T cells upon antigenic stimulation. The anergy-promoting molecular milieu and function induced by miR-150 deficiency were rescued by reinstatement of miR-150. Additionally, knockdown of TMEM20 in miR-150-deficient naïve CD8 + T cells reduced intracellular Ca 2+ levels. Our findings revealed that miR-150 play essential roles in controlling intracellular Ca 2+ level and activation in naïve CD8 + T cells, which suggest a mechanism to overcome anergy induction by the regulation of intracellular Ca 2+ levels.
Regulation of intracellular Ca
2+ signaling is a major determinant of CD8 + T cell responsiveness, but the mechanisms underlying this regulation of Ca 2+ levels, especially in naïve CD8 + T cells, are not fully defined. Here, we showed that microRNA-150 (miR-150) controls intracellular Ca 2+ levels in naïve CD8 + T cells required for activation by suppressing TMEM20, a negative regulator of Ca 2+ extrusion. miR-150 deficiency increased TMEM20 expression, which resulted in increased intracellular Ca 2+ levels in naïve CD8 + T cells. The subsequent increase in Ca 2+ levels induced expression of anergy-inducing genes, such as Cbl-b, Egr2, and p27, through activation of NFAT1, as well as reduced cell proliferation, cytokine production, and the antitumor activity of CD8 + T cells upon antigenic stimulation. The anergy-promoting molecular milieu and function induced by miR-150 deficiency were rescued by reinstatement of miR-150. Additionally, knockdown of TMEM20 in miR-150-deficient naïve CD8 + T cells reduced intracellular Ca 2+ levels. Our findings revealed that miR-150 play essential roles in controlling intracellular Ca 2+ level and activation in naïve CD8 + T cells, which suggest a mechanism to overcome anergy induction by the regulation of intracellular Ca 2+ levels.
Cluster of differentiation (CD) 8 + T cells act as key effector components in adaptive immunity by killing intracellular pathogen-infected and transformed cells. To acquire effector activity, naïve CD8 + T cells require triggering via 1) interaction of the T cell receptor (TCR) with antigenic peptide-loaded major histocompatibility complexes, and 2) engagement of co-stimulatory molecules such as CD28. In the absence of co-stimulation, TCR-stimulated naïve CD8
+ T cells cannot produce interleukin (IL)-2 and proliferate upon subsequent antigenic stimulation. This unresponsiveness of CD8 + T cells has been termed anergy 1 . Activation, as well as anergy induction, of CD8 + T cells is associated with Ca 2+ -mediated signaling. TCR stimulation increases intracellular Ca 2+ concentrations, which induce the nuclear localization of nuclear factor of activated T-cells 1 (NFAT1) 2 . Simultaneously, CD28 co-stimulation activates mitogen-activated protein kinase, which activates activator protein 1 (AP-1). Cooperation of NFAT1 with AP-1 induces expression of genes associated with T cell activation, such as IL-2, whereas NFAT1 activation without AP-1 initiates transcription of anergy-inducing genes, such as early growth-response protein 2 (Egr2) and p27 3, 4 . Additionally, naïve T cells can acquire an anergic phenotype if the intracellular Ca 2+ concentration is sustained at a high level before the TCR stimulation that accompanies co-stimulation, and such hypo-responsiveness can be normalized by blocking Ca and the regulation of intracellular Ca 2+ levels in naïve CD8 + T cells should be tightly regulated to avoid T cell anergy 5 . However, the regulating mechanism of intracellular Ca 2+ in naïve CD8 + T cells is not widely defined yet. During CD8 + T cell activation, intracellular Ca 2+ concentrations are primarily regulated by the calcium release-activated Ca 2+ (CRAC) channel and plasma membrane Ca 2+ ATPase (PMCA) 6 . TCR stimulation induces Ca 2+ release from the endoplasmic reticulum (ER) through the inositol trisphosphate receptor, and the increased cytosolic Ca 2+ level, in association with calmodulin, activates PMCA to extrude Ca 2+ from the cell. The reduced Ca 2+ concentration in the ER lumen, referred to as store depletion, triggers stromal-interacting molecule 1 (STIM1) to open the CRAC channel via interactions with CRAC channel protein 1 (ORAI1) in the plasma membrane. The opened CRAC channel causes an influx of extracellular Ca 2+ into the cell 7 . Additionally, STIM1 inhibits PMCA-mediated Ca 2+ removal from the cell 8 . The Ca
2+
-regulating activity of STIM1 is mediated by the formation of a complex with transmembrane protein 20 (TMEM20) 9 , followed by the translocation of the complex to the adjacent side of the plasma membrane, eventually enabling STIM1 to bind PMCA. Based on this Ca 2+ -regulating mechanism, TMEM20 appears to play a crucial role in CD8 + T cell activation that must be precisely regulated; however, the specific mechanism by which this occurs and the role in naïve CD8
+ T cells are largely unknown. microRNAs (miR) are noncoding RNAs about 22 nucleotides in length that mediate post-transcriptional gene regulation through translational repression and degradation of messenger RNA after binding to the 3′ untranslated region (UTR) of the target RNA 10 . Based on this regulatory activity, miRNAs, including miR-150, are widely associated with the development and biological function of immune cells. During T cell development in the thymus, miR-150 represses neurogenic locus notch-homolog protein 3, a factor involved in T cell differentiation and survival, suggesting that miR-150 is one of the controlling factors for CD8 + T cell development 11 . Recently, miR-150 was also shown to be required for CD8 + T cell activation 12 , and miR-150-deficient CD8 + T cells showed reduced proliferation, differentiation into terminal effector cells, and acquisition of effector function required for killing infected cells. Changes in the transcriptome, such as a decrease in proliferation/killing-associated RNAs and an increase in inhibitory RNAs, were suggested as a molecular mechanism associated with hypo-functional cells; however, the specific mechanism, including the direct target of miR-150 and the molecular events that followed antigenic stimulation in the absence of miR-150 in naïve CD8
+ T cells, has not been elucidated. In this study, we revealed that miR-150 is a critical factor in the prevention of an ectopic increase in intracellular Ca 2+ levels, which prevents anergy induction in naïve CD8 + T cells. Mechanistically, miR-150 suppresses increases in intracellular Ca 2+ levels by directly suppressing TMEM20 expression. This miR-150-induced reduction in TMEM20 allows naïve CD8 + T cells to remove intracellular Ca 2+ and eventually inhibits the expression of anergy-inducing genes, such as Casitas B lineage lymphoma b (Cbl-b), Egr2, and p27. These findings provide a specific molecular mechanism by which miR-150 regulates CD8 + T cell activation and affirms the central importance of intracellular Ca 2+ regulation in naïve CD8 + T cells. (Fig. 1a ) after antigen stimulation with recombinant Listeria-expressing gag Ag (Lm-gag), and they retained the characteristics of limited differentiation, including low expression of killer cell lectin-like receptor G1 (KLRG1), and high expression of CD127 (Fig. 1b) . mir-150 −/− CD8 + T cells also showed reduced function, in terms of decreased expression of effector-associated cytokines [IL-2, interferon-γ (IFN-γ), and granzyme B] and activation-/proliferation-associated molecules (cMyc, cyclin B1, T-bet, EOMES, Blimp1, IL-1β, Klrg1, Cdk6, Cdc23, and Cep120), compared with expression levels observed in mir-150 +/+ CD8 + T cells ( Fig. 1c and Fig. S1 ), which is consistent wit results in a previous report 12 . Notably, the expression of the anergy-inducing gene (Egr2) increased in mir-150 −/− CD8 + T cells (Fig. S1c) . Additionally, the antitumor activity of CD8 + T cells decreased as a result of miR-150 deficiency (Fig. 1d) . Collectively, these data suggested that miR-150 is required for proliferation, differentiation, and cytolytic activity of CD8 + T cells. To determine the molecular mechanism associated with reduced activation and functionality in mir-150 
Results

miR-150 deficiency increases intracellular
−/− CD8 + T cells,
CD8
+ T cells showed increased nuclear localization of NFAT1 and active forms of NFAT1 (dephosphorylated NFAT1) (Fig. 3a,b) . Additionally, naïve mir-150 −/− CD8 + T cells expressed anergy-inducing genes such as Cbl-b, Src-homology region 2 domain-containing phosphatase-1 (SHP-1), Egr2, and p27, at higher levels than those observed in naïve mir-150 +/+ CD8 + T cells (Fig. 3b) 4, [16] [17] [18] . mRNA levels of anergy-inducing genes, such as SHP-1, Egr2, and p27 were also upregulated (Fig. 3c) , and treatment with NFAT1 inhibitor (cyclosporine A) reduced the mRNA levels of anergy-related genes (Fig. 3d) +/+ and mir-150 −/− naïve CD8 + T cells were incubated with or without cyclosporine A (CsA, 3 µM) for 12 h and the amount of anergy-related mRNAs were measured using RT-PCR *P < 0.05, **P < 0.01, ***P < 0.001. Data are means ± SEM of duplicate triplicate samples from a single experiment and are representative of two independent experiments. level from the CD8 + T cells at 15 min incubation (down right). **P < 0.01, ***P < 0.001, ns: not significant. Data are means ± SEM of duplicate triplicate samples from a single experiment and are representative of two independent experiments.
Scientific RepoRts | 7: 2623 | DOI:10.1038/s41598-017-02697-x Mitochondrial calcium uniporter (MCU), sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) in the ER, and sodium-calcium exchanger (NCX) in the cellular membrane are also known as regulators of intracellular Ca 2+ levels 21, 22 . Thus, we also investigated whether these regulators are associated with increased intracellular Ca 2+ levels in naïve mir-150 −/− CD8 + T cells. Treatment with inhibitors of MCU (3 mM sodium cyanide + 2ug/ml oligomycin) or SERCA (1uM thapsigargin; TG) did not change intracellular Ca 2+ levels in naïve mir-150 +/+ CD8 + T cells (Fig. S5) . In NCX-inhibited conditions using sodium-free media, intracellular Ca 2+ levels in naïve mir-150 -regulation-associated molecules were unchanged (Fig. 5a ). Confocal microscopic analysis also showed that TMEM20 expression was higher and co-localization of TMEM20 with PMCA was greater in naïve mir-150
+ T cells than those in naïve mir-150 +/+ CD8 + T cells ( Fig. 5b and Fig S6) . Interestingly, TMEM20 did not seem to co-localize with STIM1 in both naïve mir-150 +/+ and mir-150 −/− CD8 + T cells, indicating that the increased intracellular Ca 2+ levels in mir-150 −/− CD8 + T cells were not associated with STIM1. Thus, TMEM20 may suppress PMCA activity in a STIM1-independent manner in naïve mir-150 −/− CD8 + T cells. To assess the potential for miR-150 to suppress TMEM20 expression specifically, we performed an arylalkylamine N-acetyltransferase (AANAT)-reporter assay as previously described 23, 24 . Based on the miRanda algorithm (www.microrna.com), the 3′UTR of TMEM20 mRNA contains a putative binding sequence for miR-150 (Fig. 5c) , and overexpression of miR-150 reduced the expression of the AANAT reporter protein but not AANAT mRNA. In contrast, forced expression of a miR-150 mutant incapable of binding to the TMEM20 3′UTR did not change AANAT expression, suggesting that miR-150 suppresses the expression of TMEM20, and has the potential to do so directly. miR-150 restoration recovers the miR-150 phenotype in miR-150-deficient CD8 + T cells. We then investigated whether miR-150 restoration could recover intracellular Ca 2+ levels and the molecular signature in naïve mir-150 −/− CD8 + T cells. We infected naïve mir-150 −/− CD8 + T cells with a retrovirus-expressing miR-150 (retro-miR-150) and analyzed the resulting cell phenotype. miR-150 restoration increased miR-150 levels in CD8 + T cells (Fig. 6a) . Furthermore, retro-miR-150 infection reduced intracellular Ca 2+ levels in mir-150 −/− CD8 + T cells to levels observed in mir-150 +/+ CD8 + T cells (Fig. 6b) . However, intracellular Ca 2+ levels in mir-150 +/+ CD8 + T cells were unchanged by the additional expression of miR-150, whereas TMEM20 expression in mir-150 −/− CD8 + T cells was reduced by restoration of miR-150 (Fig. 6c) . Additionally, retro-miR-150 infection of mir-150 −/− CD8 + T cells reduced expression of anergy-related genes Cbl-b, Egr2, and p27 and increased the expression of activation-induced molecules granzyme B, cyclin B1, and Blimp1 following anti-CD3/CD28 stimulation (Fig. 6c,d ). In addition, suppression of TMEM20 expression by infection with small interfering RNA targeting TMEM20 (siTMEM20) decreased intracellular Ca 2+ levels in naïve mir-150 −/− CD8 + T cells, indicating that the balance between TMEM20 and miR-150 regulates intracellular Ca 2+ levels in naïve CD8 + T cells (Fig. 6e ). These data suggested that miR-150 is required for activation of naïve CD8 + T cells by regulating intracellular Ca 2+ levels and preventing the expression of anergy-related genes (Fig. 6f) .
Discussion
In CD8 + T cells, increasing the concentration of intracellular Ca 2+ after TCR stimulation is essential to inducing the expression of activation-associated genes 2, 25, 26 . Because controlling the Ca 2+ concentration is crucial for T cell activation, there has been an extensive search for molecules, such as channels, transporters, and other proteins, 
cells (left). Dot graph shows intracellular Ca
2+ levels at 10 min incubation (down left) and representative images (down right) (f) Schematic cartoon for the effect of miR-150 on Ca 2+ homeostasis and induction of anergy-related genes in naïve CD8 + T cells. *P < 0.05, **P < 0.01, ***P < 0.001, ns: not significant. associated with Ca 2+ movement during T cell activation. The preconditions for increasing intracellular Ca 2+ levels during T cell activation are a relatively low level of intracellular Ca 2+ in naïve CD8 + T cells and an ectopic increase in intracellular Ca 2+ levels before T cell activation turns T cells into tolerant cells 5 . + T cells. Given that mir-150 has many targets, expression of undefined factor(s) supporting TMEM20 function could be increased in naïve mir-150 −/− CD8 + T cells, and, thereby, the increase in TMEM20 with the associated factor(s) might suppress PMCA activity in naïve mir-150 −/− CD8 + T cells before calcium store-depletion in the ER. Another possible mechanism for calcium store depletion independent of TMEM20-mediated PMCA deactivation is TMEM20 expression in the plasma membrane, which might deactivate PMCA function itself, but its function could also be limited by insufficient expression to act in naïve mir-150 +/+ CD8 + T cells. In this case, increased TMEM20 expression in naïve mir-150 −/− CD8 + T cells may be sufficient to deactivate PMCA function, resulting in the increase in intracellular Ca 2+ levels in naïve mir-150 −/− CD8 + T cells, might suppress transcription of TMEM20. Given that miR-150 has many targets, miR-150 overexpression might induce suppression of TMEM20 as well as have additional or alternative effects, and the additional effects, not suppression of TMEM20 levels, could be the reason for the decreased intracellular Ca 2+ levels in retro-miR-150-infected naïve mir-150 −/− CD8 + T cells. However, we showed that suppression of TMEM20 expression decreased the intracellular Ca 2+ levels in naïve mir-150 −/− CD8 + T cells. Thus, TMEM20 expression levels, especially in the absence of miR-150, are critical to controlling intracellular Ca 2+ levels in naïve CD8 + T cells. Whether simply overexpressing TMEM20 is sufficient to increase intracellular Ca 2+ levels in naïve mir-150 +/+ CD8 + T cells in questionable. In a previous report, TMEM20 overexpression did not change the intracellular Ca 2+ levels in HEK 293 cells expressing STIM1 and Orai1 in thapsigargin-treated conditions, but thapsigargin-untreated conditions were not tested 9 . Although we showed that miR-150 deficiency did not change the expression levels of Ca 2+ -regulating molecules, except for TMEM20, miR-150 deficiency may influence undefined factor(s) required for TMEM20 function, as described above. In this case, simply overexpressing TMEM20 might not increase intracellular Ca 2+ level in naïve mir-150 +/+ CD8 + T cell. To date, the mechanism of TMEM20 function and its associated/regulating molecules have not been widely investigated. Thus, studies on the mechanism of TMEM20 function and regulation should be conducted to better understand the detailed mechanism of Ca 2+ regulation in naïve CD8 + T cells before and after activation.
miR-150 deficiency reduces CD8 + T cell activation, in terms of expansion, differentiation, and cytolytic function 12 . Although changes in the levels of several mRNAs in response to miR-150 deficiency were suggested in a previous study to be a mechanism for the observed reduction in CD8 + T cell activation, a direct relationship between altered mRNA levels and CD8 + T cell activation-associated molecular changes was not found. In this study, we showed that TMEM20 is a direct target for miR-150 in naïve CD8
+ T cells and that the miR-150 deficiency-induced reduction in CD8 + T cell activation results from altered intracellular Ca 2+ levels. In the absence of miR-150, elevated expression of TMEM20, a Ca 2+ extruder, attenuates PMCA activity, resulting in increased intracellular Ca 2+ levels in naïve CD8 + T cells 8, 9 . This increased intracellular Ca 2+ induced activation of NFAT1, which consequently induced expression of anergy-inducing genes such as Egr2, Cbl-b, and p27 16, 17, 28 . Because anergy-inducing genes such as p27 and Egr2 are reportedly miR-150 targets, increased expression of p27 and Egr2 in mir-150 −/− CD8 + T cells may be a result of the loss of translational suppression of these mRNAs by miR-150 in mir-150 −/− naïve CD8 + T cells 29, 30 . However, following treatment with an NFAT1 inhibitor, mir-150 −/− naïve CD8 + T cells showed decreased levels of p27 and Egr2 mRNA, indicating that increased expression of anergy-inducing genes is primarily due to transcriptional regulation via the intracellular Ca 2+ /NFAT1 signaling pathway. Expression of these anergy-inducing genes related to miR-150 deficiency could explain the reduced proliferation, differentiation, and killing activity of naïve mir-150 −/− CD8 + T cells upon antigenic stimulation, as previously reported 12 and shown in our study. To avoid these miR-150-deficiency-induced molecular events, intracellular Ca 2+ levels need to be sufficiently low to prevent NFAT1 activation. It was previously reported that in effector CD8
+ T cells, miR-150 levels are lower than in naïve CD8 + T cells 13 . Given that miR-150 suppresses expression of CD25, an IL-2 receptor, reduced miR-150 levels in effector CD8 + T cells can favor survival and proliferation 31 . Relatively low levels of miR-150 in effector CD8 + T cells may also be explained by intracellular Ca 2+ -associated events. Because miR-150 deficiency elevated intracellular Ca 2+ levels, decreased levels of miR-150 in effector CD8
+ T cells implies that effector CD8 + T cells may require higher intracellular Ca 2+ concentrations to promote activity such as that of cytotoxic T lymphocytes (CTLs). Previous reports showed that intracellular Ca 2+ is involved in granule reorientation toward the target cell contact region and exocytosis of granules [32] [33] [34] . Additionally, intracellular Ca 2+ mediates the production of effector cytokines and the expression of death receptor ligands [35] [36] [37] . To mediate these diverse functions associated with CTLs, high intracellular Ca 2+ concentrations may be required, which might be satisfied by miR-150 downregulation in effector CD8 + T cells. miR-150 acts as a "fine tuner" of various immune cells. In B cells, miR-150 controls differentiation and receptor signaling [38] [39] [40] . In natural killer cells, miR-150 regulates development, as well as cytotoxicity 24, 41 . T cell differentiation and the expression of cytokine receptors are also influenced by miR-150 11, 31 . Here, we showed that miR-150 controlled Ca 2+ signaling and prevented the induction of anergy in naïve CD8 + T cells. Considering these various roles for miR-150 in immune cells and various target molecules, studies to determine additional miR-150 roles in the immune system will likely shed light on currently undefined mechanisms as well as possible therapeutic approaches using CD8 + T cells. Given the impact of miR-150 on CD8 + T cell activation, regulation of miR-150 expression may be a therapeutic target in CD8 + T cell-associated diseases. Because we showed that mir-150 −/− naïve CD8 + T cells could not be activated, CD8
+ T cell-specific suppression of miR-150 expression may be a novel approach to treating autoimmune diseases. In this context, our findings indicate a molecular mechanism that prevents the transition of CD8 + T cells into a hypo-responsive state, as well as a basis for regulation of CD8 + T cell activation.
Methods
Mice. TCR gag transgenic mice have been generated as previously described 42 . C57BL/6 (B6) mice and mir-150 −/− mice on a B6 background were purchased from The Jackson Laboratory and TCR gag :mir-150 +/+ and TCR gag :mir-150 −/− mice were generated in our animal facility. All mice were bred and maintained under Specific Pathogen Free conditions. All of the methods and experimental procedures were conducted according to the approved (approval ID: KRIBB-AEC-15088) guidelines and regulations by the animal ethics committee (IACUC) of KRIBB, South Korea.
Cell lines. The Friend virus-induced erythroleukemia of B6 origin, FBL, expresses the FMuLV-encoded gag epitope (peptide CCLCLTVFL purchased from Pi Proteomics), and was maintained in culture in RPMI1460 supplemented with 10% FBS and antibiotics. NIH3T3 cells for plasmid transfection were cultured in DMEM supplemented with 10% FBS and antibiotics.
Expansion of effector TCR gag CD8
+ T cells in vitro. −/− mice were transferred into Thy1.2 + B6 recipients. At one day after the transfer, the mice were injected with recombinant attenuated (ΔactA, ΔinlB) Listeria monocytogenes expressing the FMuLV GAG epitope (CCLCLTVFL) (Lm-gag) or a control vector (Lm-Ø) (kindly provided by Aduro BioTech, Inc) intraperitoneally. T cell persistence and proliferation were monitored in peripheral blood.
Immunofluorescence. Glass coverslips-attached cells were stimulated with CaCl 2 , PMA/Ionomycin, and anti-CD3 for indicated time points, washed using PBS, fixed in 3.7% formaldehyde for 10 min at 37 °C, permeabilized with 0.2% Triton X-100 for 10 min at room temperature, washed, and then blocked in 1% BSA in PBS Scientific RepoRts | 7: 2623 | DOI:10.1038/s41598-017-02697-x for 30 min. To visualize NFAT1, the cells were stained with anti-NFAT1 (Abcam) for 1 h, washed and incubated with FITC-conjugated anti-mouse antibody (Santa Cruz Biotechnology) for 1 h. Images were captured with an Olympus DP30BW digital camera and processed using the Metamorph 7.1 program (Universal Imaging, Media, PA, USA). Nuclear translocation of NFAT1 was measured by percentage of NFAT1 localized in the nucleus. + T cells were loaded with 2 μM fura-2/ AM (Life Technologies) for 20 min at 37 °C and attached to poly-L-lysine treated glass cover slips loaded in a Chamlide magnetic chamber (Live Cell Instrument) under Ca 2+ -free HSBB medium. The fura-2 loaded cells were perfused using HBSS medium containing 2 mM Ca 2+ . Cell images were obtained on a Zeiss Axio Observer.Z1 epifluorescence microscope. Fura-2 emission was detected at 510 nm after excitation at 340 and 380 nm. In some experiments, biotin-conjugated anti-CD3 (5 μg/ml, 2C11, BioXCell), anti-CD28 (5 μg/ml, 37.51, BioXCell) and streptavidin (10 μg/ml, Thermo Scientific) were added at the indicated time. To measure intracellular Ca 2+ concentration in the CRAC, PMCA, SERCA, or MCU inhibited conditions, CD8 + T cells were pre-treated with specific inhibitors as below and measured intracellular Ca 2+ levels as described above. CRAC inhibitor: 2-aminoethoxydiphenyl borate (2-APB, 100 uM, Sigma-Aldrich), PMCA inhibitors: La 3+ (0.3, 0.5 or 1 mM, Sigma-Aldrich) and 5(6)-carboxyeosin (20 uM, AXXORA), SERCA inhibitor: thapsigargin (1 µM, Sigma-Aldrich), MCU inhibitor: sodium cyanide (3 mM, Sigma-Aldrich) + oligomycin (2 µg/ mL, Sigma-Aldrich). For NCX inhibition, Na-free media (ThermoScientific) was used. Acquired time-lapse images and Fura 340/380 ratio images were analyzed with ImageJ software (National Institutes of Health) and Metamorph (Molecular Devices). 
Immunoblot analysis. Cytoplasmic lysates of CD8
+ T cells were extracted with PBS containing 1% NP-40 and complete proteinase inhibitor (Roche). Immunoblot analyses were performed with primary antibodies purchased from Abcam (anti-ITCH and anti-Egr2), Cell Signaling (anti-Calcineurin A, anti-NFAT1, anti-p27, and anti-STIM1), Santa Cruz Biotech (anti-Calcineurin B, anti-Cbl-b, anti-SHP-1, and anti-TMEM20), GenTex (anti-Orai1), Thermo Scientific (anti-P2X7) and AbFRONTIER (anti-GAPDH) and gifted from Dr. Klein DC (anti-AANAT). The secondary antibodies were visualized using an Immobilon Western kit (MILLIPORE).
Reverse transcription and quantitative PCR. Total RNA extracted with TRIzol (Invitrogen) was reverse transcribed with Moloney murine leukemia virus reverse transcriptase and oligo-d(T). For real-time qPCR, cDNA was amplified with specific primers and SYBR Premix Ex Taq (Takara Bio) on a Dice TP800 Thermal Cycler (Takara Bio). The mRNA levels are presented relative to expression of GAPDH mRNA. Quantitative real-time PCR of mature miR was performed with a TaqMan MicroRNA Assay kit (Applied Biosystems) as previously described 23, 24 . miR expressions are presented relative to the level of U6 small nuclear RNA.
mRNA array and data analysis. To collect naïve, effector, and memory CD8 + T cells, mice infected with Lm-gag as described in "T cell proliferation in vivo", samples were isolated from the spleen at day 0, 5, and 50 after Lm-gag infection, respectively, and analyzed the phenotype of each samples (naïve: CD8 + CD44 lo CD62L hi , effector: CD8 + CD44 hi CD62L lo , and memory: CD8 + CD44 hi CD62L hi ). Labeling of target mRNAs and hybridization were performed using Agilent's mRNA Labeling Reagent and Hybridization Kit (Agilent Technology) as manufacturer's instruction. The hybridization images were analyzed with an Agilent DNA microarray Scanner and quantified by using Agilent Feature Extraction software. Normalization and selection of all data were performed by using GeneSpring GX 7.3 (Agilent Technology). For microarray data, genes were filtered with removing flag-out genes in each experiment. In the gene expression microarray, intensity-dependent normalization (LOWESS) was performed, where the ratio was reduced to the residual of the Lowess fit of the intensity vs. ratio curve. The averages of normalized ratios were calculated by dividing the average of normalized signal channel intensity by the average of normalized control channel intensity. Functional annotation of genes was performed according to Gene Ontology TM Consortium (http://www.geneontology.org/index.shtml) by GeneSpring GX 7.3. Gene classification was based on searches done by GeneCards (http://www.genecards.org/), miRanda (http:// www.microrna.org/), DAVID (http://david.abcc.ncifcrf.gov/), and Medline databases (http://www.ncbi.nlm.nih. gov/). The microarray data can be accessed from the Gene Expression Omnibus under the accession GSE62262.
Plasmids and Reporter assay. To construct chimeric reporter plasmids pcAANAT-TMEM20, 3′UTR of the mouse TMEM20 was amplified by DNA polymerase (TAKARA) using specific primers (forward: 5′-AAGAATTCTGAAGTGTCACTGCTGA-3′ and reverse: 5′-AACTCGAGAGTTGTAAAACCCA-ACA-3 ′) and confirmed by sequencing. For AANAT reporter assays, NIH3T3 cells were co-transfected with 1 µg of pcAANAT-TMEM20 plasmids with one of either the miR-150 mimics, miR-150 mutants, or the non-targeting control (BiONEER) at concentrations of 50~100 nM using TransIT-X2 (Mirus Bio LLC). Transfected cells were further grown for 48 h before harvesting.
Scientific RepoRts | 7: 2623 | DOI:10.1038/s41598-017-02697-x Co-localization measurement of STIM1, PMEM20, and PMCA. Isolated CD8 + T cells were incubated in the presence of 2 mM of Ca 2+ , fixed with paraformaldehyde (Sigma-Aldrich), permeabilized using Triton X-100 (Sigma-Aldrich) and stained with anti-PMCA (Abcam), anti-TMEM20 (SantaCruz Biotechnology) or anti-STIM1 (Cell Signaling Technology) antibody. Then the samples were stained with anti-rabbit IgG-Alex Fluor ® 488, anti-rabbit-IgG-Alex Fluor ® 546 or IgG-Alex Fluor ® 647 (Life Technologies, Gaithersburg, MD) for PMCA, STIM1 or TMEM20, respectively. The images were obtained using LSM 510 META Laser Scanning Microscopes (Carl Zeiss).
Retrovirus preparation and transduction. pMXs-miR-GFP/puro retroviral expression vector was purchased from Cell Biolabs, Inc. To generate pMXs-miR-150-GFP, miR-150 was amplified by RT-PCR from splenocyte using primers as below: miR-150 forward primer containing XhoI site, 5′-TCG ACT CGA GAC AGG AAC CCC CTC CCT CAG C-3′; miR-150 reverse primer with XhoI site, 5′-TCG ACT CGA GGG AAG GGA CCC AAG GCA TCC C-3′. The amplified PCR product was cloned into pMXs-miR-GFP/puro after treatment with XhoI restriction enzyme. Retroviruses were generated using TransIT transfection reagents and Platinum-E retroviral packing cell line as manufacturer' protocol (Mirus Bio Corp., Madison, WI). To add-back miR-150 to CD8 + T cells, 1 × 10 6 CD8 + T cells were transduced with multiplicity of infection of 10 of retro-miR-150-GFP or retro-miR-GFP with polybrene (8 μg/mL, Sigma-Aldrich) and IL-2 (10 U/mL, R&D systems). To measure the expression levels of anergy related genes after miR-150 add-back, CD8
+ T cells were harvested at 2 d after virus infection and GFP-positive and negative populations were sorted using a FACS Aria cell sorter (BD Biosciences) and performed qPCR. For measurement of granzyme B, cyclin B1 and Blimp1, sorted GFP-positive and negative populations were incubated with anti-CD3/anti-CD28 (Life Technology) for 4 h, and PCR performed. TMEM20 knock-down study. For TMEM20 knockdown, isolated mir-150 −/− naïve CD8 + T cells were transfected with 300 pmol of siRNA (none, control, or TMEM20: CGCTGGAGTGATACTTATCGTGAGACCAC) using Amaxa nucleofector (Lonza). At 48 hr after transfection, the cells were harvested and used to measure TMEM20 mRNA levels and intracellular Ca 2+ levels as described above.
